NDC 72162-1625-06 - Spironolactone and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1625
- Requested NDC
- 72162-1625-06
- Package NDCs from labels
- 72162-1625-0, 72162-1625-1, 72162-1625-3, 72162-1625-4, 72162-1625-5, 72162-1625-6, 72162-1625-06
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-03-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Spironolactone and Hydrochlorothiazide - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-03-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1625-0 | Spironolactone and Hydrochlorothiazide | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 107 | |
| 72162-1625-1 | Spironolactone and Hydrochlorothiazide | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 107 | |
| 72162-1625-3 | Spironolactone and Hydrochlorothiazide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 107 | |
| 72162-1625-4 | Spironolactone and Hydrochlorothiazide | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 107 | |
| 72162-1625-5 | Spironolactone and Hydrochlorothiazide | 500 in 1 BOTTLE, PLASTIC | TABLET | 500 | 107 | |
| 72162-1625-6 | Spironolactone and Hydrochlorothiazide | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 107 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1625 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLET [BRYANT RANCH PREPACK] | 103 | Current NDC, 6 package rows | 20240920_b3228678-7992-4148-b4ab-aa0d8b1b8570.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1625-0 | EA - Each | 72162-1625 | 80e4d34b-73b6-43b6-b701-b03b0bfdba2d | 1 | 2024-10-04 |
| 72162-1625-1 | EA - Each | 72162-1625 | f1befe5c-8e07-47f8-85ed-e1beab4b3be1 | 1 | 2024-01-04 |
| 72162-1625-3 | EA - Each | 72162-1625 | 23581e8f-7626-4465-96cf-fc626ba87093 | 1 | 2024-01-04 |
| 72162-1625-4 | EA - Each | 72162-1625 | 85002e63-3d8d-4018-8a71-957594fac2dd | 1 | 2025-08-11 |
| 72162-1625-5 | EA - Each | 72162-1625 | 32249ef1-7f3d-4710-999f-8fd434d1cc35 | 1 | 2024-03-12 |
| 72162-1625-6 | EA - Each | 72162-1625 | bd5d6bc5-d262-42a8-916f-d7d7d91f9763 | 1 | 2024-01-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SPIRONOLACTONE | SPIRONOLACTONE | Bryant Ranch Prepack | ca194a2a-ed16-40f6-a78c-45c5f3392170 | 2026-11-02 | Warnings, Adverse reactions | 27O7W4T232 |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 9c68d45d-e4c8-4f6f-9ca5-faadc056e6e7 | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | St. Mary's Medical Park Pharmacy | b2d444ee-588d-37a9-e053-2a95a90ad2f1 | 2026-10-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| Exforge HCT | AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE | Novartis Pharmaceuticals Corporation | 18d7820d-471f-4ee2-9ec6-25d8d27c77de | 2026-10-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| SPIRONOLACTONE | SPIRONOLACTONE | REMEDYREPACK INC. | 860b08bf-c6c1-4310-8510-10b6779f3d59 | 2026-10-28 | Warnings, Adverse reactions | 27O7W4T232 |
| spironolactone | SPIRONOLACTONE | REMEDYREPACK INC. | 39d82d50-0b77-4ef5-96b8-c1e05044a82c | 2026-10-28 | Warnings, Adverse reactions | 27O7W4T232 |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 36fbc5fc-4a75-4aa3-bed1-78944135ae11 | 2026-10-28 | Warnings, Adverse reactions | 0J48LPH2TH |
| spironolactone | SPIRONOLACTONE | Cardinal Health 107, LLC | 96db5dee-7c01-4f96-8b1e-1fcd2103d0fe | 2026-10-28 | Warnings, Adverse reactions | 27O7W4T232 |
| Senna S | DOCUSATE SODIUM AND SENNOSIDES | Marlex Pharmaceuticals Inc | 9c87759f-3856-4f30-b5ea-4b37ed90f18c | 2026-10-27 | Warnings | F05Q2T2JA0 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 89d367b1-de04-4970-9967-27a1c7711c0f | 2026-10-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | 67bedecc-f758-4bc6-82c5-7d428cbbbd9b | 2026-10-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 447c11b6-72fe-418e-a2db-5d90b5347796 | 2026-10-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 2106032d-5678-4c25-b8a7-f19ac2afafd4 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 24d40f18-b98c-48fc-8d97-5f3e351afc31 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Umedica Laboratories USA Inc. | 55d6aee1-01ca-4791-8404-386664b4ab07 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Lifestar Pharma LLC | 9771066e-c05d-6a93-e053-2995a90a7e87 | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Docusate Mini Enema | DOCUSATE SODIUM | Major Pharmaceuticals | 91099e15-94d7-b684-e053-2a95a90a574e | 2026-10-23 | Warnings | F05Q2T2JA0 |
| CVS Mini Enema | DOCUSATE SODIUM W/BENZOCAINE | CVS HEALTH | ca00c520-410a-1905-e053-2995a90a56f0 | 2026-10-23 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | ATLANTIC BIOLOGICALS CORP. | c1f588d0-4600-4b97-b2d3-2c08ac351e07 | 2026-10-23 | Warnings | F05Q2T2JA0 |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.